Siva Gandhapudi
Director Immunology & Product Development at PDS Biotechnology- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
Telugu Native or bilingual proficiency
-
Hindi Limited working proficiency
-
Tamil Limited working proficiency
Topline Score
Bio
Greg Conn
Siva has been one of the leading molecular immunologists in our company for many years, responsible for the design, execution and analysis of most of the major biological studies on our drug platforms. He is thoughtful, enthusiastic, familiar with the scientific literature and works effectively with our team. He routinely develops applications for new technology and has a broad experience with sophisticated techniques in immunological analysis including ELISA, ELISPOT, and flow cytometry. His work has included both in vitro experimental technique and extensive use of in vivo animal models to develop novel immunotherapeutic treatments and vaccines. A valued colleague in our company's scientific organization.
Angela Mohs
I have collaborated with Siva Gandhapudi, while I was a Senior Scientist at PDS Biotechnology. Siva supported the in vivo and in vitro testing of cancer vaccine formulations at PDS Biotechnology. He has always been enthusiastic about his work and his technical expertise made a major impact on the advancement of cancer vaccine design and development.
Greg Conn
Siva has been one of the leading molecular immunologists in our company for many years, responsible for the design, execution and analysis of most of the major biological studies on our drug platforms. He is thoughtful, enthusiastic, familiar with the scientific literature and works effectively with our team. He routinely develops applications for new technology and has a broad experience with sophisticated techniques in immunological analysis including ELISA, ELISPOT, and flow cytometry. His work has included both in vitro experimental technique and extensive use of in vivo animal models to develop novel immunotherapeutic treatments and vaccines. A valued colleague in our company's scientific organization.
Angela Mohs
I have collaborated with Siva Gandhapudi, while I was a Senior Scientist at PDS Biotechnology. Siva supported the in vivo and in vitro testing of cancer vaccine formulations at PDS Biotechnology. He has always been enthusiastic about his work and his technical expertise made a major impact on the advancement of cancer vaccine design and development.
Greg Conn
Siva has been one of the leading molecular immunologists in our company for many years, responsible for the design, execution and analysis of most of the major biological studies on our drug platforms. He is thoughtful, enthusiastic, familiar with the scientific literature and works effectively with our team. He routinely develops applications for new technology and has a broad experience with sophisticated techniques in immunological analysis including ELISA, ELISPOT, and flow cytometry. His work has included both in vitro experimental technique and extensive use of in vivo animal models to develop novel immunotherapeutic treatments and vaccines. A valued colleague in our company's scientific organization.
Angela Mohs
I have collaborated with Siva Gandhapudi, while I was a Senior Scientist at PDS Biotechnology. Siva supported the in vivo and in vitro testing of cancer vaccine formulations at PDS Biotechnology. He has always been enthusiastic about his work and his technical expertise made a major impact on the advancement of cancer vaccine design and development.
Greg Conn
Siva has been one of the leading molecular immunologists in our company for many years, responsible for the design, execution and analysis of most of the major biological studies on our drug platforms. He is thoughtful, enthusiastic, familiar with the scientific literature and works effectively with our team. He routinely develops applications for new technology and has a broad experience with sophisticated techniques in immunological analysis including ELISA, ELISPOT, and flow cytometry. His work has included both in vitro experimental technique and extensive use of in vivo animal models to develop novel immunotherapeutic treatments and vaccines. A valued colleague in our company's scientific organization.
Angela Mohs
I have collaborated with Siva Gandhapudi, while I was a Senior Scientist at PDS Biotechnology. Siva supported the in vivo and in vitro testing of cancer vaccine formulations at PDS Biotechnology. He has always been enthusiastic about his work and his technical expertise made a major impact on the advancement of cancer vaccine design and development.
Credentials
-
Clinical Research Coordinator (CRC)
CITI Program, A Division of BRANYOct, 2020- Oct, 2024 -
Graduate Certificate in Improving Healthcare Value (Finance and Business)
Gatton College of Business and EconomicsDec, 2019- Oct, 2024 -
GCP Course for Clinical Trials Involving Investigational Drugs (international / ICH focus)
CITI Program, A Division of BRANYOct, 2020- Oct, 2024 -
Global commerce and Strategies Specialist
World Trade Center Kentucky -
Lean Six Sigma Green Belt
LeanCor Supply Chain Group
Experience
-
PDS Biotechnology
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Director Immunology & Product Development
-
Sep 2021 - Present
-
-
Consultant Scientist
-
Nov 2015 - Nov 2021
-
-
-
University of Kentucky College of Medicine
-
Higher Education
-
400 - 500 Employee
-
Scientist IV
-
Nov 2015 - Present
Research activates: • Assist pharmaceutical industry collaborator as consultant scientist in the development of human cancer, and infectious disease vaccines using novel Versamune ® technology. • Design, develop and oversee pre-clinical studies for testing the immunogenicity and efficacy of cancer vaccine formulations for human clinical trials. • Develop novel Combination Immunotherapy approaches for Cancer treatment. • Operations Manager for the Human Immune Monitoring Core… Show more Research activates: • Assist pharmaceutical industry collaborator as consultant scientist in the development of human cancer, and infectious disease vaccines using novel Versamune ® technology. • Design, develop and oversee pre-clinical studies for testing the immunogenicity and efficacy of cancer vaccine formulations for human clinical trials. • Develop novel Combination Immunotherapy approaches for Cancer treatment. • Operations Manager for the Human Immune Monitoring Core facility. Show less Research activates: • Assist pharmaceutical industry collaborator as consultant scientist in the development of human cancer, and infectious disease vaccines using novel Versamune ® technology. • Design, develop and oversee pre-clinical studies for testing the immunogenicity and efficacy of cancer vaccine formulations for human clinical trials. • Develop novel Combination Immunotherapy approaches for Cancer treatment. • Operations Manager for the Human Immune Monitoring Core… Show more Research activates: • Assist pharmaceutical industry collaborator as consultant scientist in the development of human cancer, and infectious disease vaccines using novel Versamune ® technology. • Design, develop and oversee pre-clinical studies for testing the immunogenicity and efficacy of cancer vaccine formulations for human clinical trials. • Develop novel Combination Immunotherapy approaches for Cancer treatment. • Operations Manager for the Human Immune Monitoring Core facility. Show less
-
-
-
University of Oklahoma
-
United States
-
Higher Education
-
700 & Above Employee
-
Postdoctoral Research Fellow
-
Nov 2013 - Jun 2015
Research Activities: • Developed human blood Immunophenotyping protocol for assessment of inflammatory signatures in patients with psychological disorders. • Identified a potential combination cytokine therapy approach for treating Lymphopenia. Research Activities: • Developed human blood Immunophenotyping protocol for assessment of inflammatory signatures in patients with psychological disorders. • Identified a potential combination cytokine therapy approach for treating Lymphopenia.
-
-
-
University of Louisville
-
United States
-
Higher Education
-
700 & Above Employee
-
Postdoctoral Research Associate
-
Mar 2010 - Oct 2013
Research activities: • Helped industrial collaborator in the drug discovery phase through efficacy evaluation studies. • Carried out pre-clinical animal studies for evaluating immunogenicity, efficacy, and safety of candidate TLR vaccine adjuvants. • Characterized reactogenicity of TLR adjuvants using human neutrophils and PBMCs. Research activities: • Helped industrial collaborator in the drug discovery phase through efficacy evaluation studies. • Carried out pre-clinical animal studies for evaluating immunogenicity, efficacy, and safety of candidate TLR vaccine adjuvants. • Characterized reactogenicity of TLR adjuvants using human neutrophils and PBMCs.
-
-
-
University of Kentucky
-
United States
-
Higher Education
-
700 & Above Employee
-
Graduate Research assistant
-
Aug 2004 - Oct 2009
Research Activities: • Evaluated cationic nanoparticle as antigen delivery systems for infectious disease vaccines. • Characterized T cell responses to physiological stress and identified potential mechanism protecting T cells from physiological stress. Research Activities: • Evaluated cationic nanoparticle as antigen delivery systems for infectious disease vaccines. • Characterized T cell responses to physiological stress and identified potential mechanism protecting T cells from physiological stress.
-
-
Education
-
2017 - 2019
Gatton College of Business and Economics
Master of Business Administration - MBA, Business Administration, Management and Operations -
2004 - 2009
University of Kentucky
Ph.D, Microbiology and Immunology -
2002 - 2004
University of Kentucky
Master of Science - MS, Soil Microbiology -
1996 - 2000
Acharya N.G. Ranga Agricultural University
Bachelor of Science - BS, Agriculture
Community
